Beranda › Kanker Endometrium
Uji klinis Kanker Endometrium yang merekrut di AS
168 studi untuk Kanker Endometrium merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX68 studi
- New York City, NY52 studi
- Boston, MA50 studi
- Arlington, VA39 studi
- Nashville, TN38 studi
- Los Angeles, CA34 studi
- St. Louis, MO29 studi
- Philadelphia, PA28 studi
- San Antonio, TX27 studi
- Queens, NY25 studi
- Columbus, OH25 studi
- Chicago, IL25 studi
- Oklahoma City, OK25 studi
- Dallas, TX24 studi
- Portland, OR24 studi
- Pittsburgh, PA23 studi
- Detroit, MI21 studi
- Cleveland, OH20 studi
- Rochester, MN20 studi
- Edison, NJ19 studi
- Washington, DC18 studi
- Minneapolis, MN18 studi
- Grand Rapids, MI18 studi
- Orlando, FL17 studi
- Atlanta, GA17 studi
- Seattle, WA17 studi
- Baldwin Park, CA17 studi
- Durham, NC16 studi
- Miami, FL16 studi
- Birmingham, AL16 studi
- San Diego, CA16 studi
- Austin, TX15 studi
- Denver, CO15 studi
- Tampa, FL15 studi
- Sarasota, FL15 studi
- New Haven, CT14 studi
- Providence, RI14 studi
- Salt Lake City, UT14 studi
- Indianapolis, IN14 studi
- Aurora, CO14 studi
Berdasarkan negara bagian
- Alabama19 studi
- Alaska4 studi
- Arizona22 studi
- Arkansas12 studi
- California73 studi
- Colorado30 studi
- Connecticut20 studi
- Delaware4 studi
- Distrik Columbia10 studi
- Florida65 studi
- Georgia24 studi
- Hawaii3 studi
- Idaho4 studi
- Illinois38 studi
- Indiana19 studi
- Iowa10 studi
- Kansas5 studi
- Kentucky10 studi
- Louisiana15 studi
- Maine7 studi
- Maryland22 studi
- Massachusetts53 studi
- Michigan43 studi
- Minnesota39 studi
- Mississippi5 studi
- Missouri31 studi
- Montana5 studi
- Nebraska10 studi
- Nevada8 studi
- New Jersey32 studi
- New Mexico13 studi
- New York69 studi
- North Carolina31 studi
- North Dakota6 studi
- Ohio50 studi
- Oklahoma28 studi
- Oregon27 studi
- Pennsylvania42 studi
- Rhode Island14 studi
- South Carolina9 studi
- South Dakota11 studi
- Tennessee41 studi
- Texas91 studi
- Utah25 studi
- Virginia51 studi
- Washington20 studi
- West Virginia4 studi
- Wisconsin24 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Tirzepatide in Obesity-Driven Endometrial Cancer
Menerima pesertaFase awal 1
Usia 18 ke atas · Wanita · Diperbarui 2 Okt 2026 · NCT07065552Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Menerima pesertaFase 2
Semua usia · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05564377Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Wanita · Diperbarui 2 Okt 2026 · NCT05950464The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 2 Okt 2026 · NCT07286331A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06270706Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 2 Okt 2026 · NCT07198074A Phase 1 Study of the Safety and Tolerability of CTX-10726
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07419841Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Menerima pesertaFase 2
Usia 18 hingga 72 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT01174121A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1
Usia 19 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06586957A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07189871The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07285044A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07814248Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Menerima pesertaStudi observasional
Usia 18 ke atas · Wanita · Diperbarui 29 Sep 2026 · NCT05051722Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 28 Sep 2026 · NCT05112601Study of AVZO-021 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05867251DESTINY-PANTUMOUR04
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06218914ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 25 Sep 2026 · NCT07270666Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Menerima pesertaFase 1/2
Usia 18 ke atas · Wanita · Diperbarui 25 Sep 2026 · NCT03564340Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 24 Sep 2026 · NCT07594015A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Menerima pesertaFase 1/2
Usia 18 ke atas · Wanita · Diperbarui 24 Sep 2026 · NCT04590326Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.